Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Honda, Kazufumi ^a   Okusaka, Takuji ^b   Felix, Klaus ^c   Nakamori, Shoji ^d   Sata, Naohiro ^e   Nagai, Hideo ^e   Ioka, Tatsuya ^f   Tsuchida, Akihiko ^g   Shimahara, Takeshi ^h   Shimahara, Masashi ^h   Yasunami, Yohichi ⁱ   Kuwabara, Hideya ^j   Sakuma, Tomohiro ^j   Otsuka, Yoshihiko ^k   Ota, Norihito ^k   Shitashige, Miki ^a   Kosuge, Tomoo ^b   Büchler, Markus W ^c   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d NATIONAL HOSPITAL ORGANIZATION   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g TOKYO MEDICAL UNIVERSITY   (Japan)

^h OSAKA MEDICAL COLLEGE   (Japan)

ⁱ FUKUOKA UNIVERSITY   (Japan)

^j Mitsui Knowledge Industry Co   (Japan)

^k Molecuence Corporation   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A2; APOLIPOPROTEIN C3; CA 19-9 ANTIGEN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; APOLIPOPROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84867300937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046908     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Lowenfels AB, Maisonneuve P, (2004) Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34: 238-244.
3. Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, et al. (2010) Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol 21: 441-447.
4. Okusaka T, Yamada T, Maekawa M, (2006) Serum tumor markers for pancreatic cancer: the dawn of new era? Jop 7: 332-336.
5. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, et al. (2005) Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 65: 10613-10622.
6. Diamandis EP, (2006) Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Cancer Res 66: 5540-5541.
7. Ehmann M, Felix K, Hartmann D, Schnolzer M, Nees M, et al. (2007) Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34: 205-214.
8. Hartmann D, Felix K, Ehmann M, Schnolzer M, Fiedler S, et al. (2007) Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis. Pancreas 35: 334-342.
9. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, et al. (1998) Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383-1393.
10. Ono M, Matsubara J, Honda K, Sakuma T, Hashiguchi T, et al. (2009) Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. J Biol Chem 284: 29041-29049.
11. Sato S, Idogawa M, Honda K, Fujii G, Kawashima H, et al. (2005) beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology 129: 1225-1236.
12. Kikuchi S, Honda K, Handa Y, Kato H, Yamashita K, et al. (2007) Serum albumin-associated peptides of patients with uterine endometrial cancer. Cancer Sci 98: 822-829.
13. Yamaguchi U, Nakayama R, Honda K, Ichikawa H, Hasegawa T, et al. (2008) Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 26: 4100-4108.
14. Pankhurst G, Wang XL, Wilcken DE, Baernthaler G, Panzenbock U, et al. (2003) Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J Lipid Res 44: 349-355.
15. Ito Y, Breslow JL, Chait BT, (1989) Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure. J Lipid Res 30: 1781-1787.
16. Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD, (1999) Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J Lipid Res 40: 543-555.
17. Issaq HJ, Veenstra TD, Conrads TP, Felschow D, (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292: 587-592.
18. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577.
19. Baggerly KA, Morris JS, Coombes KR, (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20: 777-785.
20. Yamamoto M, Ohashi O, Saitoh Y, (1998) Japan Pancreatic Cancer Registry: current status. Pancreas 16: 238-242.
21. Sata N, Kurashina K, Nagai H, Nagakawa T, Ishikawa O, et al. (2009) The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Surg 16: 485-492.
22. Tanaka S, Nakaizumi A, Ioka T, Takakura R, Uehara H, et al. (2004) Periodic ultrasonography checkup for the early detection of pancreatic cancer: preliminary report. Pancreas 28: 268-272.
23. Safi F, Schlosser W, Kolb G, Beger HG, (1997) Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms. J Gastrointest Surg 1: 106-112.
24. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116: 271-284.
25. Matsugi S, Hamada T, Shioi N, Tanaka T, Kumada T, et al. (2007) Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clin Chim Acta 378: 147-153.
26. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, et al. (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76: 1560-1570.